These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 18828709)

  • 1. Hydrodynamic limb vein injection of adeno-associated virus serotype 8 vector carrying canine myostatin propeptide gene into normal dogs enhances muscle growth.
    Qiao C; Li J; Zheng H; Bogan J; Li J; Yuan Z; Zhang C; Bogan D; Kornegay J; Xiao X
    Hum Gene Ther; 2009 Jan; 20(1):1-10. PubMed ID: 18828709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice.
    Qiao C; Li J; Jiang J; Zhu X; Wang B; Li J; Xiao X
    Hum Gene Ther; 2008 Mar; 19(3):241-54. PubMed ID: 18288893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adeno-associated virus-mediated expression of myostatin propeptide improves the growth of skeletal muscle and attenuates hyperglycemia in db/db mice.
    Jiang JG; Shen GF; Li J; Qiao C; Xiao B; Yan H; Wang DW; Xiao X
    Gene Ther; 2017 Mar; 24(3):167-175. PubMed ID: 27983718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adeno-associated virus-8-mediated intravenous transfer of myostatin propeptide leads to systemic functional improvements of slow but not fast muscle.
    Foster K; Graham IR; Otto A; Foster H; Trollet C; Yaworsky PJ; Walsh FS; Bickham D; Curtin NA; Kawar SL; Patel K; Dickson G
    Rejuvenation Res; 2009 Apr; 12(2):85-94. PubMed ID: 19405813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A canine minidystrophin is functional and therapeutic in mdx mice.
    Wang B; Li J; Qiao C; Chen C; Hu P; Zhu X; Zhou L; Bogan J; Kornegay J; Xiao X
    Gene Ther; 2008 Aug; 15(15):1099-106. PubMed ID: 18432277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic myostatin inhibition via liver-targeted gene transfer in normal and dystrophic mice.
    Morine KJ; Bish LT; Pendrak K; Sleeper MM; Barton ER; Sweeney HL
    PLoS One; 2010 Feb; 5(2):e9176. PubMed ID: 20161803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AAV-mediated delivery of a mutated myostatin propeptide ameliorates calpain 3 but not alpha-sarcoglycan deficiency.
    Bartoli M; Poupiot J; Vulin A; Fougerousse F; Arandel L; Daniele N; Roudaut C; Noulet F; Garcia L; Danos O; Richard I
    Gene Ther; 2007 May; 14(9):733-40. PubMed ID: 17330087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term systemic myostatin inhibition via liver-targeted gene transfer in golden retriever muscular dystrophy.
    Bish LT; Sleeper MM; Forbes SC; Morine KJ; Reynolds C; Singletary GE; Trafny D; Pham J; Bogan J; Kornegay JN; Vandenborne K; Walter GA; Sweeney HL
    Hum Gene Ther; 2011 Dec; 22(12):1499-509. PubMed ID: 21787232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures.
    Kornegay JN; Bogan DJ; Bogan JR; Dow JL; Wang J; Fan Z; Liu N; Warsing LC; Grange RW; Ahn M; Balog-Alvarez CJ; Cotten SW; Willis MS; Brinkmeyer-Langford C; Zhu H; Palandra J; Morris CA; Styner MA; Wagner KR
    Skelet Muscle; 2016; 6():14. PubMed ID: 27047655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular, cellular and physiological investigation of myostatin propeptide-mediated muscle growth in adult mice.
    Matsakas A; Foster K; Otto A; Macharia R; Elashry MI; Feist S; Graham I; Foster H; Yaworsky P; Walsh F; Dickson G; Patel K
    Neuromuscul Disord; 2009 Jul; 19(7):489-99. PubMed ID: 19541486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment of rAAV-Mediated Expression of Myostatin Propeptide Lowers Type 2 Diabetes Incidence in
    Yan H; Meng J; Zhang S; Zhuang H; Song Y; Xiao X; Wang DW; Jiang J
    Hum Gene Ther; 2019 May; 30(5):661-671. PubMed ID: 30526118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term functional adeno-associated virus-microdystrophin expression in the dystrophic CXMDj dog.
    Koo T; Okada T; Athanasopoulos T; Foster H; Takeda S; Dickson G
    J Gene Med; 2011 Sep; 13(9):497-506. PubMed ID: 22144143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transduction efficiency and immune response associated with the administration of AAV8 vector into dog skeletal muscle.
    Ohshima S; Shin JH; Yuasa K; Nishiyama A; Kira J; Okada T; Takeda S
    Mol Ther; 2009 Jan; 17(1):73-80. PubMed ID: 18941441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice.
    Koo T; Popplewell L; Athanasopoulos T; Dickson G
    Hum Gene Ther; 2014 Feb; 25(2):98-108. PubMed ID: 24191945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products.
    Yuasa K; Yoshimura M; Urasawa N; Ohshima S; Howell JM; Nakamura A; Hijikata T; Miyagoe-Suzuki Y; Takeda S
    Gene Ther; 2007 Sep; 14(17):1249-60. PubMed ID: 17581597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Widespread muscle expression of an AAV9 human mini-dystrophin vector after intravenous injection in neonatal dystrophin-deficient dogs.
    Kornegay JN; Li J; Bogan JR; Bogan DJ; Chen C; Zheng H; Wang B; Qiao C; Howard JF; Xiao X
    Mol Ther; 2010 Aug; 18(8):1501-8. PubMed ID: 20517298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A GDF11/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice.
    Jin Q; Qiao C; Li J; Xiao B; Li J; Xiao X
    Skelet Muscle; 2019 May; 9(1):16. PubMed ID: 31133057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single intravenous injection of adeno-associated virus serotype-9 leads to whole body skeletal muscle transduction in dogs.
    Yue Y; Ghosh A; Long C; Bostick B; Smith BF; Kornegay JN; Duan D
    Mol Ther; 2008 Dec; 16(12):1944-52. PubMed ID: 18827804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy in skeletal muscle mediated by adeno-associated virus vectors.
    Qiao C; Koo T; Li J; Xiao X; Dickson JG
    Methods Mol Biol; 2011; 807():119-40. PubMed ID: 22034028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies.
    Cordier L; Gao GP; Hack AA; McNally EM; Wilson JM; Chirmule N; Sweeney HL
    Hum Gene Ther; 2001 Jan; 12(2):205-15. PubMed ID: 11177557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.